基于网络药理学探讨十全大补汤治疗肌少症的作用机制OA
Exploring the Mechanism of Shiquan Dabu Decoction in Treating Sarcopenia Based on Network Pharmacology
本文基于网络药理学和机器学习,探讨十全大补汤治疗肌少症的作用机制.采用中药系统药理学数据库与分析平台(Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform,TCMSP)、中药靶点预测工具(Bioinformatics Analysis Tool for Molecular mechanism of Traditional Chinese Medicine,BATMAN-TCM)、人类孟德尔遗传数据库(Online Mendelian Inheritance in Man,OMIM)、人类基因综合数据库(The Human Gene Da-tabase,GeneCards)并整合基因表达综合数据库(Gene Expression Omnibus,GEO),检索十全大补汤的活性成分、作用靶点与肌少症疾病靶点;取成分靶点与肌少症疾病靶点,制作韦恩图,得出共同靶点,利用蛋白质相互作用数据库(Search Tool for the Retrieval of Interacting Genes,STRING)和Cytoscape 3.10.0软件构建活性成分-肌少症共同靶点网络图、蛋白互作网络图,筛选关键靶点与核心靶点;通过注释、可视化和整合发现数据库(Database for Annota-tion,Visualization and Integrated Discovery,DAVID)进行基因本体(Gene Ontology,GO)和京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)信号通路富集分析,Cytoscape 3.10.0软件绘制"药物-化合物-疾病-靶点-通路"网络图;结合蛋白质-蛋白质相互作用(Protein-protein Interaction,PPI)网络筛选的潜在靶点,并结合机器学习筛选出核心靶点;利用贡献指数算法筛选关键化合物,对核心靶点基因和关键化合物开展分子对接.细胞实验采用毛蕊异黄酮干预D-半乳糖诱导的C2C12衰老成肌细胞,以CCK-8法筛选毛蕊异黄酮最佳作用浓度,采用实时荧光定量逆转录聚合酶链式反应(Real-time Quantitative Reverse Transcription Polymerase Chain Re-action,RT-qPCR)技术验证其对核心靶点mRNA的表达.共获得十全大补汤活性成分176个及其作用靶点316个、肌少症相关基因14 778个、十全大补汤活性成分与肌少症疾病共同靶点246个、十全大补汤治疗肌少症核心靶点58个,AKT1、IL-6、TNF、INS、IL1B、TP53、PTGS2、CASP3、JUN、STAT3居前10位;肿瘤坏死因子、胰岛素信号通路等是十全大补汤改善肌少症的主要通路;机器学习筛选出CASP3、JUN为关键基因;通过贡献指数算法,筛选出槲皮素、山柰酚、儿茶素、异鼠李素、木犀草素、毛蕊异黄酮为主要活性成分;分子对接表明,6个化合物与两个关键基因结合能均小于-20.92 kJ/mol.基于CCK-8法的细胞活性分析结果显示,6.25 µmol/L毛蕊异黄酮对D-半乳糖诱导的C2C12细胞增殖活性最强.RT-qPCR结果表明,与对照组相比,D-半乳糖(40 mg/mL)处理组细胞的JUN基因相对表达量显著升高(P<0.01),毛蕊异黄酮显著降低了JUN的相对表达量(P<0.001).槲皮素、山柰酚、儿茶素、异鼠李素、木犀草素、毛蕊异黄酮为十全大补汤干预肌少症的主要活性成分,可能通过靶向关键基因CASP3、JUN,发挥治疗肌少症的作用.本研究为十全大补汤"多成分-多靶点-多通路"治疗肌少症作用机制提供了现代诠释.
The objective of this study is to explore the potential mechanism of Shiquan Dabu Decoction(SQDBT)in treating sarcope-nia based on network pharmacology and machine learning.Active components and targets of SQDBT,as well as sarcopenia-related targets,were obtained from TCMSP,BATMAN-TCM,OMIM,GeneCards and GEO databases.Venn diagram was used to obtain common targets of SQDBT and sarcopenia.STRING and Cytoscape 3.10.0 were applied to construct relevant networks and screen key/core targets.GO and KEGG enrichment analysis were conducted via DAVID,and Cytoscape 3.10.0 was used to draw the"drug-compound-disease-target-pathway"network.Core targets were screened by combining PPI network with machine learning,and key compounds by contribution index algorithm.Molecular docking was performed for core targets and key compounds.In the experi-mental section,D-galactose-induced C2C12 senescent myoblasts were intervened with calycosin.The optimal effective concentra-tion of calycosin was screened by the CCK-8 assay,and RT-qPCR was used to verify its effect on the mRNA expression of core tar-gets.A total of 176 active components(317 targets)of SQDBT,14 785 sarcopenia-related genes,246 common targets and 58 core targets of SQDBT for sarcopenia were identified.The top 10 core targets were AKT1,IL-6,TNF,INS,IL1B,TP53,PTGS2,CASP3,JUN and STAT3.TNF and insulin signaling pathways were the main regulatory pathways.CASP3 and JUN as key genes were identi-fied by machine learning and Quercetin,kaempferol,catechin,isorhamnetin,luteolin and calycosin as main active components were screened by contribution index algorithm.Results of molecular docking showed that the binding affinities of the 6 compounds with the two key genes were all lower than-20.92 kJ/mol.CCK-8 assay indicated that 6.25 µmol/L calycosin had the strongest effect on the proliferation of D-galactose-induced C2C12 cells.The qRT-PCR results showed that D-galactose(40 mg/mL)significantly up-regulated JUN expression(P<0.01),while calycosin significantly down-regulated it(P<0.001).Quercetin,kaempferol,catechin,isor-hamnetin,luteolin and calycosin are the main active components of SQDBT for sarcopenia,which may exert therapeutic effects by targeting CASP3 and JUN.This study provides a modern interpretation of the action mechanism of Shiquan Dabu Decoction in treat-ing sarcopenia with multiple components-multiple targets-multiple pathways.
赵佳琪;陈子龙;王玥;樊晓杰;李震宇;秦雪梅;何盼
山西中医药大学 太行本草研究院,山西 晋中 030619||山西中医药大学 中药与食品工程学院,山西 晋中 030619山西中医药大学 太行本草研究院,山西 晋中 030619||山西中医药大学 中药与食品工程学院,山西 晋中 030619山西中医药大学 太行本草研究院,山西 晋中 030619山西中医药大学 太行本草研究院,山西 晋中 030619山西中医药大学 太行本草研究院,山西 晋中 030619||山西大学 中医药现代研究中心,山西 太原 030006山西中医药大学 太行本草研究院,山西 晋中 030619||山西大学 中医药现代研究中心,山西 太原 030006山西中医药大学 太行本草研究院,山西 晋中 030619
医药卫生
十全大补汤肌少症网络药理学机器学习贡献指数分子对接
Shiquan Dabu Decoctionsarcopenianetwork pharmacologymachine learningcontribution indexmolecular docking
《山西大学学报(自然科学版)》 2026 (5)
788-802,15
国家自然科学基金(82405058)山西省基础研究计划青年项目(202403021212248)山西中医药大学博士科研启动基金(2024BK05)来晋科研启动基金项目(2024BKS01)山西中医药大学科技创新能力培育计划"基础与临床合作研究专项"(2025PY-JL-28-01)山西省卫健委中医药科研课题(2024ZYYA026)山西省中医药科技创新工程项目(2024kjzy002)中药生命组学与创新药物研发研究室(zyyyjs2024019)
评论